-
AI VIVO seeks collaboration partners to progress top-ranked COVID-19 therapeutic candidates
May 7, 2020, 11:02 AM by Michael CroftCAMBRIDGE, UK - May 7, 2020 -Full story- 41 of the candidate drugs from AI VIVO's top-ranked list for COVID-19 are now in clinical trials for COVID-19 by multiple groups globally
- Demonstrates the ability of AI VIVO's unique phenotypic drug discovery methodology to identify and rank therapeutic candidates
- AI VIVOselected other drugs as single and combinations from their top-ranked list and seeks partners with pharma companies and clinical trial investigators
-
CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic
May 7, 2020, 10:41 AM by Michael CroftKING OF PRUSSIA, PA, US - May 7, 2020 - CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software for clinical trials, today announced that its recently launched complimentary COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies that are directly affected by Covid-19Full story -
KCR’s Bryan Katz named in PM360’s ELITE 100
May 7, 2020, 10:17 AM by Michael CroftBOSTON, MA - May 7, 2020 - KCR, the international clinical development solutions provider, announced today that its Chief Commercial Officer, Bryan Katz, was honored by healthcare marketing industry trade magazine PM360 as one of their 2020 ELITE 100 award winnersFull story -
Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system
May 7, 2020, 07:19 AM by Michael CroftGUILDFORD, UNITED KINGDOM - May 7, 2020 - For use in advanced medical research into inflammation, oncology and nephritis the 7T PET-MR imaging system from MR Solutions provides a combination of PET and MRI images either simultaneously or separatelyFull story -
Covid-19 Volunteer Testing Network scaling up - delivering tests for GPs and care home workers
May 7, 2020, 06:12 AM by Michael CroftOXFORD, UK - May 7, 2020 -Full story- The Covid-19 Volunteer Testing Network is scaling up towards thousands of tests per day
- 6 labs around the country are now live with 20 more in the pipeline
- Local labs can deliver a fast-turnaround for their nearby GPs and care home workers
- One lab in the network identified an outbreak in a community care provider with asymptomatic staff testing positive
- Underscores the vital importance of regular screening of healthcare workers who might otherwise unknowingly be spreading the virus
-
Halfpenny Technologies, an Accumen Company, Launches COVID-19 Test Capacity and Routing Network Across 870 U.S. Hospitals to Accelerate Diagnostic Testing
May 6, 2020, 20:05 PM by Michael CroftPHOENIX, AZ - May 6, 2020 - Halfpenny Technologies, Inc., a wholly owned subsidiary of Accumen, Inc., today announced the launch of its COVID-19 Test Capacity and Routing Network (The Network)Full story -
Widening Application Scope and COVID-19 Crisis, Set to Boost Market Growth of Immunoassays, Concludes Fact.MR
May 6, 2020, 10:00 AM by Michael CroftDUBLIN 2, IRELAND - May 6, 2020 - As the number of chronic and infectious diseases compound, medical advancements have grown in equal proportionFull story -
Lessons From Personalized Medicine Can Supercharge Coronavirus Testing
May 6, 2020, 08:15 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Months into the Covid-19 pandemic, the United States remains dangerously behind on testing—and we know that technology from personalized medicine can help correct the chaos.
-
Rho Experts Share Regulatory Best Practices on Product Development for the New Coronavirus
May 5, 2020, 10:50 AM by Michael CroftRESEARCH TRIANGLE PARK, NC, UNITED STATES - May 5, 2020 - WHAT: Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will outline new information from the Food and Drug Administration (FDA) on the new coronavirus (COVID-19) pandemic as it relates to ongoing and planned clinical research in an upcoming webinar, "Potential COVID-19 Products: Choosing the Right Path with FDAFull story -
GRAIL Founder Returns To Illumina As CTO
May 4, 2020, 16:45 PM by Michael CroftBio-IT World | Illumina today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic.Full story -
SEKISUI XenoTech Expands Access to Top-Tier DDI Expertise & Consultancy
May 4, 2020, 09:27 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - May 4, 2020 - SEKISUI XenoTech is expanding opportunities for clients to work with top-tier consultants to evaluate drug-drug interaction potential of their drug candidate and bolster their preclinical data package for regulatory submissionFull story -
Follow the Money: New European Fund, All-Flash Storage, More
May 4, 2020, 08:55 AM by Michael CroftBio-IT World | New life sciences fund closes in Europe, big investments in VAST Data’s all flash storage, AI-written code, Lifebit’s CloudOS, Scopio Labs’s digital microscopy, microbiome tests and much more.Full story -
Blockchain and its Impact on Epidemiology for COVID-19
May 4, 2020, 08:15 AM by Michael CroftFull storyBio-IT World Contributed Commentary | With the recent outbreak of COVID-19, epidemiologists around the world are researching and creating models on how to contain the disease. Blockchain technology exemplifies its use case within epidemiology by streamlining the process of distribution and providing trustworthy data.
-
CHELSIO AND RYUSSI DEMONSTRATE END-TO-END iWARP RDMA BETWEEN WINDOWS 10 ENTERPRISE AND MoSMB SMB3 SERVER
May 3, 2020, 05:33 AM by Michael CroftSUNNYVALE, CALIFORNIA - Feb 12, 2020 - Chelsio Communications, Inc., a leading provider of high performance (1Gb/10Gb/25Gb/40Gb/50Gb/100Gb) Ethernet Unified Wire adapters and ASICs for storage networking, virtualized enterprise datacenters, cloud service installations, and cluster computing environments, and Ryussi America, Inc, a Storage & Systems Product Development and Consulting company, today announced the results of the performance of Chelsio Terminator 6 (T6) iWARP RDMA adapters with Windows 10 Enterprise Client RDMA feature enabling high-speed access to the Ryussi MoSMB SMB3 server using SMB DirectFull story -
Data Kits, Supercomputers, And Llamas: Bio-IT Community Leaves No Stone Unturned In COVID-19 Research
May 1, 2020, 09:00 AM by Michael CroftBio-IT World | New insights from the global bio-IT community show progress in fight against COVID-19.Full story -
The New Technology CAR-T Is Expected to Overcome AIDS After Being Transformed
May 1, 2020, 08:01 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 1, 2020 - CAR-T is the short name for Chimeric Antigen Receptor T-Cell Immunotherapy. To put it simply, CAR-T is to transform the patient's immune T cells in vitro to make them recognize the antigens on the surface of tumor cells, and then transfer these cells back to the patient to achieve the therapeutic effect of identifying and killing cancer cellsFull story -
Igneous Launches Data Discovery Product
Apr 30, 2020, 11:00 AM by Michael CroftFull storyBio-IT World Earlier this week, Igneous, the SaaS data management company for file-intensive environments announced enhancements to DataDiscover and DataFlow. Igneous DataFlow now enables data-heavy organizations to move data in native format from where it lives to where it needs to be, on-premises or cloud. Igneous DataDiscover catalogs all data where it lives. Now organizations can enable end users to see their data their way and find what’s important to them.
-
PHARMASEAL expands Engility® Trial Management Platform with the addition of eTMF Document Storage
Apr 30, 2020, 06:32 AM by Michael CroftNOTTINGHAN, UK - Apr 29, 2020 - PHARMASEAL, an innovative provider of enterprise trial management solutions expands the capability of the Engility® clinical trial management platformFull story -
Creative Diagnostics Launches SARS-CoV-2 Antigens and Antibodies for Research Use
Apr 30, 2020, 04:35 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Apr 1, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches SARS-CoV-2 antigens and antibodies for global researchers working on the novel coronavirusFull story -
COVID-19, Insilico Medicine, Discngine, And More: News From April 2020
Apr 29, 2020, 09:40 AM by Michael CroftFull storyBio-IT World April featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Discngine and Insilico Medicine, as well as recent attempts to combat COVID-19.